Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51
This study has been completed.
Information provided by:
First received: January 4, 2008
Last updated: June 29, 2011
Last verified: June 2011
The study investigates the long term safety and immunogenicity of the Japanese Encephalitis vaccine IC51 up to month 60.
Biological: Japanese Encephalitis purified inactivated vaccine
|Study Design:||Observational Model: Cohort|
|Official Title:||Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51. An Uncontrolled Phase 3 Follow-up Study|
Resource links provided by NLM:
Further study details as provided by Intercell AG:
Contacts and Locations